Paula M. Calvert

Dunmore Road, X91 ER8E
Waterford, M, Ireland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Unusual Presentation of Non-Gestational Extragonadal Choriocarcinoma.

Unusual Presentation of Non-Gestational Extragonadal Choriocarcinoma.

Journal: Cureus

Published: November 20, 2024

Niraparib Population Pharmacokinetics and Exposure-Response Relationships in Patients With Newly Diagnosed Advanced Ovarian Cancer.

Niraparib Population Pharmacokinetics and Exposure-Response Relationships in Patients With Newly Diagnosed Advanced Ovarian Cancer.

Journal: Clinical therapeutics

Published: January 30, 2024

Case Series: Cemiplimab and Nivolumab Immunotherapy as Promising Treatment in Advanced or Metastatic Cutaneous Squamous Cell Carcinoma.

Case Series: Cemiplimab and Nivolumab Immunotherapy as Promising Treatment in Advanced or Metastatic Cutaneous Squamous Cell Carcinoma.

Journal: Case reports in oncology

Published: August 03, 2023

Social supports in patients with cancer attending an Irish cancer center: a cross-sectional study.

Social supports in patients with cancer attending an Irish cancer center: a cross-sectional study.

Journal: The oncologist

Published: April 14, 2023

Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.

Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.

Journal: Cancer

Published: June 27, 2022

Chemotherapy Toxicity in Older Adults Optimized by Geriatric Assessment and Intervention: A Non-Comparative Analysis.

Chemotherapy Toxicity in Older Adults Optimized by Geriatric Assessment and Intervention: A Non-Comparative Analysis.

Journal: Current oncology (Toronto, Ont.)

Published: June 03, 2022

Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study.

Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study.

Journal: Gynecologic oncology

Published: February 25, 2022

Case Report: Thrombotic-Thrombocytopenic Purpura Following Ipilimumab and Nivolumab Combination Immunotherapy for Metastatic Melanoma.

Case Report: Thrombotic-Thrombocytopenic Purpura Following Ipilimumab and Nivolumab Combination Immunotherapy for Metastatic Melanoma.

Journal: Frontiers in immunology

Published: February 07, 2022

The prognostic value of the derived neutrophil-to-lymphocyte ratio (dNLR) in patients treated with immune checkpoint inhibitors.

The prognostic value of the derived neutrophil-to-lymphocyte ratio (dNLR) in patients treated with immune checkpoint inhibitors.

Journal: Irish journal of medical science

Published: November 20, 2021

Colonic Metastasis of Primary Lung Cancer.

Colonic Metastasis of Primary Lung Cancer.

Journal: Case reports in oncology

Published: April 12, 2021

Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study.

Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study.

Journal: Breast cancer research and treatment

Published: January 10, 2021

Maintaining a Medical Oncology Service during the Covid-19 Pandemic.

Maintaining a Medical Oncology Service during the Covid-19 Pandemic.

Journal: Irish medical journal

Published: July 01, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026